Summary

Eligibility
for people ages 1 month to 12 months (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around

Description

Summary

Official Title

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants: ValEAR Trial

Details

Keywords

Cmv Congenital, CMV, Congenital Cmv, SNHL, Sensorineural Hearing Loss, valganciclovir, Hearing Loss, Deafness, Simple Syrup

Eligibility

Locations

  • UCSF Benioff Children's Hospital
    San Francisco California 94158 United States
  • Lucile Packard Children's Hospital
    Palo Alto California 94304 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Albert Park
ID
NCT03107871
Phase
Phase 2 research study
Study Type
Interventional
Participants
Expecting 52 study participants
Last Updated